- Home
- WSBK vs ALEC Comparison
WSBK vs ALEC Comparison
Compare WSBK & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WSBK
- ALEC
- Stock Information
- Founded
- WSBK 2024
- ALEC 2013
- Country
- WSBK United States
- ALEC United States
- Employees
- WSBK N/A
- ALEC N/A
- Industry
- WSBK
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WSBK
- ALEC Health Care
- Exchange
- WSBK NYSE
- ALEC Nasdaq
- Market Cap
- WSBK 86.4M
- ALEC 124.0M
- IPO Year
- WSBK N/A
- ALEC 2019
- Fundamental
- Price
- WSBK $9.42
- ALEC $1.33
- Analyst Decision
- WSBK
- ALEC Buy
- Analyst Count
- WSBK 0
- ALEC 7
- Target Price
- WSBK N/A
- ALEC $4.70
- AVG Volume (30 Days)
- WSBK 76.7K
- ALEC 1.2M
- Earning Date
- WSBK 01-01-0001
- ALEC 05-08-2025
- Dividend Yield
- WSBK N/A
- ALEC N/A
- EPS Growth
- WSBK N/A
- ALEC N/A
- EPS
- WSBK 0.02
- ALEC N/A
- Revenue
- WSBK $15,687,000.00
- ALEC $88,339,000.00
- Revenue This Year
- WSBK N/A
- ALEC N/A
- Revenue Next Year
- WSBK N/A
- ALEC $392.45
- P/E Ratio
- WSBK $568.59
- ALEC N/A
- Revenue Growth
- WSBK N/A
- ALEC N/A
- 52 Week Low
- WSBK $8.91
- ALEC $0.87
- 52 Week High
- WSBK $10.10
- ALEC $6.78
- Technical
- Relative Strength Index (RSI)
- WSBK N/A
- ALEC 55.51
- Support Level
- WSBK N/A
- ALEC $1.01
- Resistance Level
- WSBK N/A
- ALEC $1.46
- Average True Range (ATR)
- WSBK 0.00
- ALEC 0.12
- MACD
- WSBK 0.00
- ALEC 0.02
- Stochastic Oscillator
- WSBK 0.00
- ALEC 71.11
About WSBK WINCHESTER BANCORP INC
Winchester Bancorp Inc provides a variety of financial services to individuals and small businesses through its offices in Winchester, Woburn, Danvers and Arlington, Massachusetts. Its primary deposit products are checking, savings and term certificate accounts and its primary lending products are residential and commercial real estate loans.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.